Silvia Rasi^1*, Sara Monti^1*, Manuela Zanni^1*, Carmela Ciardullo^1*, Fary Diop^1*, Lavinia Martuscelli^1*, Elisa Spaccarotella^1*, Valeria Spina^1*, Alessio Bruscaggin^1*, Simone Favini^1*, Clara Deambrogi^1*, Antonio Ramponi^2*, Gianluca Gaidano^1* and Davide Rossi, MD, PhD¹

¹Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
²Division of Pathology, Ospedale Maggiore della Carità, Novara, Italy

Zachary Hunter, PhD^1*, Lian Xu^1*, Guang Yang, PhD¹, Nicholas Tsakmaklis^1*, Xia Liu, MD^1*, Jie Chen, PhD^1*, Robert R Manning^1*, Jiaji Chen^1*, Christopher J Patterson, MFA^1*, Jorge J Castillo, MD², Kenneth C Anderson, MD³, Nikhil C. Munshi, MD³ and Steven P Treon, MD, PhD¹

¹Bing Center for WM, Dana Farber Cancer Institute, Boston, MA
²Division of Hematologic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
³Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA

Fabrice Jardin, MD, PhD^1*, Anais Pujals, PhD^2*, Laura Pelletier, PhD^3*, Elodie Bohers, PhD^4*, Vincent Camus^1*, Sylvain Mareschal^4*, Sydney Dubois^4*, Marlène Ochman, MD^5*, Francois Lemonnier, MD^6*, Pierre-Julien Viailly^1*, Philippe Bertrand, PhD^4*, Catherine Maingonnat^4*, Alexandra Traverse-Glehen^7*, Philippe Gaulard, MD, PhD^8*, Diane Damotte, MD, PhD^9*, Richard Delarue, MD¹⁰, Corinne Haioun, MD, PhD¹¹, Yosef Landesman, PhD^12*, William Senapedis, PhD^13*, Christian Argueta, PhD^14*, Gilles Andre Salles, MD, PhD¹⁵, Jean-Philippe Jais, MD, PhD^16*, Martin Figeac, PhD^17*, Christiane Copie-Bergman, MD, PhD^8*, Thierry Molina^18*, Jean-Michel Picquenot, PhD^19*, Marie Cornic^20*, Thierry Fest, MD, PhD^21,22*, Noel Milpied²³, Emilie Lemasle, MD^24*, Aspasia Stamatoullas, MD^25*, Peter Moeller, MD²⁶, Martin JS Dyer, MA, DPhil, FRCP, FRCPath²⁷, Christer Sundstrom, MD, PhD²⁸, Christian Bastard, MD, PhD^20*, Hervé Tilly, MD, PhD⁴ and Karen Leroy, MD, PhD^29*

¹Centre Henri Becquerel, INSERM U918, Rouen, France
²APHP Hospital Henri Mondor, U955 Team 09, Creteil, France
³APHP Hospital Henri Mondor, Inserm U955 Team 09,, Creteil, France
⁴INSERM U918, Centre Henri Becquerel, Rouen, France
⁵CHU Pontchaillou, Inserm U917, rennes, France
⁶Hematology Department, Pitie-Salpetriere Hospital, Paris, France
⁷Department of Pathology and Hematology, Hospices Civils de Lyon, University Lyon 1, Lyon, France
⁸Inserm U955 Team 09,, Creteil, France
⁹Pathology Department, CHU Cochin Paris, Paris, France
¹⁰Hematology Department, AP-HP Hôpital Necker, Paris, France
¹¹Lymphoid Malignancies Unit, AP-HP, Groupe Hospitalier Mondor, Créteil, France
¹²Karyopharm Therapeutics Inc., Newton, MA
¹³Karyopharm Therapeutics, Inc, Newton, MA
¹⁴Karyopharm Therapeutics, Newton, MA
¹⁵Centre Hospitalier Lyon-Sud, Pierre-Benite, France
¹⁶Hopital Necker, Department of Biostatistics, Paris, France
¹⁷Université de Lille 2, Lille, France
¹⁸Department of Pathology, Hôpital Necker, Paris, France
¹⁹Cancer Research Center Henri Becquerel, ROUEN, France
²⁰INSERM U918, Rouen, France
²¹INSERM U917 - CHU de Rennes, Rennes, France
²²CHU Pontchaillou, Inserm U917, RENNES, France
²³Service d’Hematologie Clinique et Therapie Cellulaire, CHU Haut-Lévêque, Bordeaux, France
²⁴Centre Henri Becquerel, INSERM U918, rouen, France
²⁵Clinical Hematology, CENTRE HENRI BECQUEREL, Rouen, France
²⁶Institute of Pathology, University of Ulm, Ulm, Germany
²⁷Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, United Kingdom
²⁸department of Pathology, Upsala, Sweden
²⁹INSERM U955, AP-HP Hôpital Henri Mondor, Creteil, France

David M. Kurtz, MD¹, Florian Scherer, MD^2*, Aaron M. Newman, PhD^2*, Alexander F. Lovejoy, PhD^3*, Daniel M. Klass, PhD^4*, Jacob J. Chabon^5*, Sanjiv Gambhir, MD, PhD^6*, Maximilian Diehn, MD, PhD^3* and Ash A. Alizadeh, MD, PhD²

¹Department of Medicine, Divisions of Hematology & Oncology; Department of Bioengineering, Stanford University Medical Center, Stanford, CA
²Department of Medicine, Divisions of Hematology & Oncology, Stanford University Medical Center, Stanford, CA
³Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA
⁴Roche, Pleasanton, CA
⁵Institute of Stem Cell Biology, Stanford University, Stanford, CA
⁶Department of Radiology, Stanford University, Stanford, CA

Yan Asmann, PhD¹, Vivekananda Sarangi, MS^2*, Chen Wang, PhD^2*, Matthew J Maurer, MS², Stephen Ansell, MD, PhD³, Andrew L Feldman, MD³, Grzegorz S. Nowakowski, MD⁴, Thomas M. Habermann, MD⁴, Anne J. Novak, Ph.D.⁴, Susan L. Slager, PhD², Brian K Link, MD⁵ and James Cerhan, MD, PhD²

¹Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL
²Department of Health Sciences Research, Mayo Clinic, Rochester, MN
³Mayo Clinic, Rochester, MN
⁴Division of Hematology, Mayo Clinic, Rochester, MN
⁵Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA

Constance Regina Baer, PhD^*, Frank Dicker, PhD, Wolfgang Kern, MD, Torsten Haferlach and Claudia Haferlach, MD

MLL Munich Leukemia Laboratory, Munich, Germany